La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model

Identifieur interne : 000228 ( PascalFrancis/Curation ); précédent : 000227; suivant : 000229

Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model

Auteurs : Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Daniel Levesque [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]

Source :

RBID : Pascal:03-0237958

Descripteurs français

English descriptors

pA  
A01 01  1    @0 0091-3952
A02 01      @0 ADNRA3
A03   1    @0 Adv. neurol.
A05       @2 86
A08 01  1  ENG  @1 Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model
A09 01  1  ENG  @1 Parkinson's disease
A11 01  1    @1 BLANCHET (Pierre J.)
A11 02  1    @1 CALON (Frédéric)
A11 03  1    @1 MORISSETTE (Marc)
A11 04  1    @1 GOULET (Martin)
A11 05  1    @1 GRONDIN (Richard)
A11 06  1    @1 LEVESQUE (Daniel)
A11 07  1    @1 BEDARD (Paul J.)
A11 08  1    @1 DI PAOLO (Thérèse)
A12 01  1    @1 CALNE (Donald) @9 ed.
A12 02  1    @1 CALNE (Susan M.) @9 ed.
A14 01      @1 Neurosciences Research Unit, Hôpital Saint-Luc du CHUM @2 Montreal, Québec H2X 3J4 @3 CAN @Z 1 aut.
A14 02      @1 Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL @2 Québec G1V 4G2 @3 CAN @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 8 aut.
A14 03      @1 Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL @2 Québec G1V 4G2 @3 CAN @Z 6 aut. @Z 7 aut.
A15 01      @1 Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon @2 Vancouver, British Columbia @3 CAN @Z 1 aut. @Z 2 aut.
A18 01  1    @1 World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders" @3 INC @9 patr.
A18 02  1    @1 Pacific Parkinsons Research Institute @3 CAN @9 patr.
A20       @1 337-344
A21       @1 2001
A23 01      @0 ENG
A43 01      @1 INIST @2 15741 @5 354000109446770340
A44       @0 0000 @1 © 2003 INIST-CNRS. All rights reserved.
A45       @0 35 ref.
A47 01  1    @0 03-0237958
A60       @1 P @2 C
A61       @0 A
A64 01  1    @0 Advances in neurology
A66 01      @0 USA
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Parkinson maladie @5 01
C03 01  X  ENG  @0 Parkinson disease @5 01
C03 01  X  SPA  @0 Parkinson enfermedad @5 01
C03 02  X  FRE  @0 Récepteur dopaminergique @5 17
C03 02  X  ENG  @0 Dopamine receptor @5 17
C03 02  X  SPA  @0 Receptor dopaminérgico @5 17
C03 03  X  FRE  @0 Primates @2 NS @5 19
C03 03  X  ENG  @0 Primates @2 NS @5 19
C03 03  X  SPA  @0 Primates @2 NS @5 19
C03 04  X  FRE  @0 Traitement @5 20
C03 04  X  ENG  @0 Treatment @5 20
C03 04  X  SPA  @0 Tratamiento @5 20
C03 05  X  FRE  @0 Chimiothérapie @5 21
C03 05  X  ENG  @0 Chemotherapy @5 21
C03 05  X  SPA  @0 Quimioterapia @5 21
C03 06  X  FRE  @0 Modèle animal @5 22
C03 06  X  ENG  @0 Animal model @5 22
C03 06  X  SPA  @0 Modelo animal @5 22
C07 01  X  FRE  @0 Mammalia @2 NS
C07 01  X  ENG  @0 Mammalia @2 NS
C07 01  X  SPA  @0 Mammalia @2 NS
C07 02  X  FRE  @0 Vertebrata @2 NS
C07 02  X  ENG  @0 Vertebrata @2 NS
C07 02  X  SPA  @0 Vertebrata @2 NS
C07 03  X  FRE  @0 Système nerveux pathologie @5 37
C07 03  X  ENG  @0 Nervous system diseases @5 37
C07 03  X  SPA  @0 Sistema nervioso patología @5 37
C07 04  X  FRE  @0 Système nerveux central pathologie @5 38
C07 04  X  ENG  @0 Central nervous system disease @5 38
C07 04  X  SPA  @0 Sistema nervosio central patología @5 38
C07 05  X  FRE  @0 Encéphale pathologie @5 39
C07 05  X  ENG  @0 Cerebral disorder @5 39
C07 05  X  SPA  @0 Encéfalo patología @5 39
C07 06  X  FRE  @0 Extrapyramidal syndrome @5 40
C07 06  X  ENG  @0 Extrapyramidal syndrome @5 40
C07 06  X  SPA  @0 Extrapiramidal síndrome @5 40
C07 07  X  FRE  @0 Maladie dégénérative @5 41
C07 07  X  ENG  @0 Degenerative disease @5 41
C07 07  X  SPA  @0 Enfermedad degenerativa @5 41
N21       @1 146
N82       @1 PSI
pR  
A30 01  1  ENG  @1 Parkinson's Disease. International Congress @3 Vancouver CAN @4 1999-07-25

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:03-0237958

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model</title>
<author>
<name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J." last="Blanchet">Pierre J. Blanchet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Neurosciences Research Unit, Hôpital Saint-Luc du CHUM</s1>
<s2>Montreal, Québec H2X 3J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Calon, Frederic" sort="Calon, Frederic" uniqKey="Calon F" first="Frédéric" last="Calon">Frédéric Calon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Levesque, Daniel" sort="Levesque, Daniel" uniqKey="Levesque D" first="Daniel" last="Levesque">Daniel Levesque</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J." last="Bedard">Paul J. Bedard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237958</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237958 INIST</idno>
<idno type="RBID">Pascal:03-0237958</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A95</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000228</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model</title>
<author>
<name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J." last="Blanchet">Pierre J. Blanchet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Neurosciences Research Unit, Hôpital Saint-Luc du CHUM</s1>
<s2>Montreal, Québec H2X 3J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Calon, Frederic" sort="Calon, Frederic" uniqKey="Calon F" first="Frédéric" last="Calon">Frédéric Calon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Levesque, Daniel" sort="Levesque, Daniel" uniqKey="Levesque D" first="Daniel" last="Levesque">Daniel Levesque</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J." last="Bedard">Paul J. Bedard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint>
<date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal model</term>
<term>Chemotherapy</term>
<term>Dopamine receptor</term>
<term>Parkinson disease</term>
<term>Primates</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Récepteur dopaminergique</term>
<term>Primates</term>
<term>Traitement</term>
<term>Chimiothérapie</term>
<term>Modèle animal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0091-3952</s0>
</fA01>
<fA02 i1="01">
<s0>ADNRA3</s0>
</fA02>
<fA03 i2="1">
<s0>Adv. neurol.</s0>
</fA03>
<fA05>
<s2>86</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG">
<s1>Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG">
<s1>Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1">
<s1>BLANCHET (Pierre J.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>CALON (Frédéric)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>MORISSETTE (Marc)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>GOULET (Martin)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>GRONDIN (Richard)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>LEVESQUE (Daniel)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>BEDARD (Paul J.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>DI PAOLO (Thérèse)</s1>
</fA11>
<fA12 i1="01" i2="1">
<s1>CALNE (Donald)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1">
<s1>CALNE (Susan M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01">
<s1>Neurosciences Research Unit, Hôpital Saint-Luc du CHUM</s1>
<s2>Montreal, Québec H2X 3J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA15 i1="01">
<s1>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1">
<s1>World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders"</s1>
<s3>INC</s3>
<s9>patr.</s9>
</fA18>
<fA18 i1="02" i2="1">
<s1>Pacific Parkinsons Research Institute</s1>
<s3>CAN</s3>
<s9>patr.</s9>
</fA18>
<fA20>
<s1>337-344</s1>
</fA20>
<fA21>
<s1>2001</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>15741</s2>
<s5>354000109446770340</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>03-0237958</s0>
</fA47>
<fA60>
<s1>P</s1>
<s2>C</s2>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Advances in neurology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Récepteur dopaminergique</s0>
<s5>17</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Dopamine receptor</s0>
<s5>17</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Receptor dopaminérgico</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Primates</s0>
<s2>NS</s2>
<s5>19</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Primates</s0>
<s2>NS</s2>
<s5>19</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Primates</s0>
<s2>NS</s2>
<s5>19</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>20</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>20</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>20</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Chimiothérapie</s0>
<s5>21</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Chemotherapy</s0>
<s5>21</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Quimioterapia</s0>
<s5>21</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Modèle animal</s0>
<s5>22</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Animal model</s0>
<s5>22</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Modelo animal</s0>
<s5>22</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>146</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
<pR>
<fA30 i1="01" i2="1" l="ENG">
<s1>Parkinson's Disease. International Congress</s1>
<s3>Vancouver CAN</s3>
<s4>1999-07-25</s4>
</fA30>
</pR>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000228 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000228 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:03-0237958
   |texte=   Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022